019736 S70 M5 vr mqr 10211 10212 dlq
Document text
SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 1 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072704 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 2 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072705 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 3 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072706 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 4 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072707 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 5 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072708 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 6 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072709 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 7 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072710 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 8 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072711 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 9 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072712 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 10 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072713 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 11 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072714 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 12 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072715 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 13 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072716 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 14 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072717 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 15 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072718 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 16 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072719 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 17 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072720 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 18 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072721 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 19 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072722 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 20 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072723 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 21 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072724 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 22 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072725 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 23 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072726 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 24 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072727 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 25 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072728 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 26 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072729 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 27 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072730 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 28 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072731 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 29 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072732 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 30 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072733 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 31 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072734 SARS-CoV-2 dLIA Linearity Qualification Data re VR-MQR-10211 and VR-MQR-10212 Experimental Data Listing - Linearity PFIZER CONFIDENTIAL Page 32 090177e194aedf59\Approved\Approved On: 18-Aug-2020 21:20 (GMT) (b) (4) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1072735